CG>TG mutation frequency as negative predictor of homologous recombination deficiency in ovarian and breast cancer.

There is a clear trend in precision medicine towards more comprehensive sequencing especially for patients for which all approved treatment lines have been exhausted and national WES and WGS programs have been set up in The Netherlands, United Kingdom, Germany, and other countries 29 – 31 .

also in 19,460 other papers